Opioids Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Opioids Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Opioids market.
This research report categorizes the global Opioids market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
In 2017, the global Opioids market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Opioids market based on company, product type, application and key regions.
The various contributors involved in the value chain of Opioids include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioids include
Table of Contents - Guidelines
1 Study Coverage
1.1 Opioids Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioids Market Size Growth Rate by Type
1.4.2 Morphine
1.4.3 Codeine
1.4.4 Methadone
1.4.5 Meperidine
1.4.6 Fentanyl
1.5 Market by Application
1.5.1 Global Opioids Market Size Growth Rate by Application
1.5.2 Anesthesia
1.5.3 Cough Suppressant
1.5.4 Diarrhea suppressant
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioids Market Size
2.1.1 Global Opioids Revenue 2016-2025
2.1.2 Global Opioids Sales 2016-2025
2.2 Opioids Growth Rate by Regions
2.2.1 Global Opioids Sales by Regions
2.2.2 Global Opioids Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioids Sales by Manufacturers
3.1.1 Opioids Sales by Manufacturers
3.1.2 Opioids Sales Market Share by Manufacturers
3.1.3 Global Opioids Market Concentration Ratio (CR5 and HHI)
3.2 Opioids Revenue by Manufacturers
3.2.1 Opioids Revenue by Manufacturers (2016-2018)
3.2.2 Opioids Revenue Share by Manufacturers (2016-2018)
3.3 Opioids Price by Manufacturers
3.4 Opioids Manufacturing Base Distribution, Product Types
3.4.1 Opioids Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Product Category
3.4.3 Date of International Manufacturers Enter into Opioids Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Opioids Sales by Type
4.2 Global Opioids Revenue by Type
4.3 Opioids Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Opioids Breakdown Data by Application
6 North America
6.1 North America Opioids by Countries
6.1.1 North America Opioids Sales by Countries
6.1.2 North America Opioids Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioids by Type
6.3 North America Opioids by Application
6.4 North America Opioids by Company
7 Europe
7.1 Europe Opioids by Countries
7.1.1 Europe Opioids Sales by Countries
7.1.2 Europe Opioids Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioids by Type
7.3 Europe Opioids by Application
7.4 Europe Opioids by Company
8 Asia Pacific
8.1 Asia Pacific Opioids by Countries
8.1.1 Asia Pacific Opioids Sales by Countries
8.1.2 Asia Pacific Opioids Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioids by Type
8.3 Asia Pacific Opioids by Application
8.4 Asia Pacific Opioids by Company
9 Central & South America
9.1 Central & South America Opioids by Countries
9.1.1 Central & South America Opioids Sales by Countries
9.1.2 Central & South America Opioids Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioids by Type
9.3 Central & South America Opioids by Application
9.4 Central & South America Opioids by Company
10 Middle East and Africa
10.1 Middle East and Africa Opioids by Countries
10.1.1 Middle East and Africa Opioids Sales by Countries
10.1.2 Middle East and Africa Opioids Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioids by Type
10.3 Middle East and Africa Opioids by Application
10.4 Middle East and Africa Opioids by Company
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Opioids
11.1.4 Opioids Product Description
11.1.5 Recent Development
11.2 Purdue Pharma
11.2.1 Purdue Pharma Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Opioids
11.2.4 Opioids Product Description
11.2.5 Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Opioids
11.3.4 Opioids Product Description
11.3.5 Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Opioids
11.4.4 Opioids Product Description
11.4.5 Recent Development
11.5 Actavis Plc
11.5.1 Actavis Plc Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Opioids
11.5.4 Opioids Product Description
11.5.5 Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Opioids
11.6.4 Opioids Product Description
11.6.5 Recent Development
11.7 Sun Pharmaceutical Industries Ltd
11.7.1 Sun Pharmaceutical Industries Ltd Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Opioids
11.7.4 Opioids Product Description
11.7.5 Recent Development
11.8 Mallinckrodt Pharmaceuticals
11.8.1 Mallinckrodt Pharmaceuticals Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Opioids
11.8.4 Opioids Product Description
11.8.5 Recent Development
11.9 Endo Pharmaceuticals Inc
11.9.1 Endo Pharmaceuticals Inc Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Opioids
11.9.4 Opioids Product Description
11.9.5 Recent Development
11.10 Egalet
11.10.1 Egalet Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Opioids
11.10.4 Opioids Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Opioids Raw Material
13.1.2 Opioids Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..